- Headquarters
- San Diego
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- radionetics.com
- Total Funding
- $222.5M
- Last Round
- $140.0M Corporate RoundJul 2024
- Rounds
- 3
About
Radionetics Oncology is a clinical-stage biopharmaceutical company founded in 2021 and headquartered in San Diego, California. It is developing novel small molecule radioligands targeting G-protein coupled receptors (GPCRs) for the treatment of a broad range of solid tumors including breast and lung cancer. In July 2024, Lilly paid $140 million upfront and secured the exclusive right to acquire Radionetics for $1 billion.
Summary
Radionetics Oncology is a Biotech company based in San Diego, United States, founded in 2021. It has raised $222.5M in total across 3 rounds, most recently a $140.0M Corporate Round round in Jul 2024. Investors include Frazier Life Sciences, 5AM Ventures and Eli Lilly.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform